Is PHBBF Stock Undervalued?
A comprehensive valuation analysis of Pharmaron Beijing Co., Ltd. (PHBBF) examining current multiples, intrinsic value, and comparing to analyst expectations.
Valuation Verdict
Potentially Undervalued
1065702316242.2% upside potential
Based on our analysis, Pharmaron Beijing Co., Ltd. appears to be potentially undervalued at the current price of $1.93. Our fair value estimate of $20568054705.41 suggests upside potential of approximately 1065702316242.2%.
Current Valuation Metrics
Valuation ratios help us understand how the market is pricing PHBBF relative to its fundamentals. Let's examine the key multiples investors are paying today.
Understanding the Metrics
- P/E Ratio: At 16.08x earnings, PHBBF is trading near the typical market average of 15-20x.
- P/B Ratio: A P/B of 1.98 means investors pay $1.98 for every $1 of book value.
- P/S Ratio: The price-to-sales ratio of 0.25 indicates how much investors value each dollar of revenue.
- EV/EBITDA: This ratio of 18.47 helps compare PHBBF to peers while accounting for debt.
Fair Value Estimate
Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Pharmaron Beijing Co., Ltd. stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.
Our DCF model suggests PHBBF may be undervalued by approximately 1065702316242.2%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.
Investment Conclusion
Bottom Line
Based on our comprehensive valuation analysis, Pharmaron Beijing Co., Ltd. (PHBBF) appears to be undervalued at $1.93. With a fair value estimate of $20568054705.41, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.
More Analysis for PHBBF
Compare with Peers
See how Pharmaron Beijing Co., Ltd. stacks up against similar companies
Popular Valuation Analysis
Explore valuation analysis for top stocks
Related: PHBBF Dividend, PHBBF Growth, PHBBF Financial Health
Compare: PHBBF vs AAPL, PHBBF vs MSFT, PHBBF vs GOOGL